/
Medicinal chemicals & botanical products company · WY · FY ends Jan · Revenue $17K · -1457.11% margin
The business is unprofitable at the operating level (-437.78% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 26.1% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$17K
▼ -26.1% YoY
Net Income (TTM)
-$474K
▲ +11.3% YoY
Op. Margin
-1457.11%
▲ +196.4pp YoY
ROIC
—
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$10K
▲ +62.2% YoY
Net Debt
-$692.00
Net Cash Position
Cash & Equiv.
$692.00
3Y CAGR: +119.9%
Continue Research